Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Fitzpatrick

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advance for Nurse Practitioners|December 17, 2009
When should older adults stop driving?Camille Fitzpatrick
Academic Medicine : Journal of the Association of American Medical Colleges|July 9, 2004
University of California, Irvine, College of MedicineAnne E Musser, Camille Fitzpatrick, Laura Mosqueda
Gerontology & Geriatrics Education|October 7, 2006
Student Senior Partnership Program: University of California Irvine School of MedicineCamille Fitzpatrick, Anne Musser, Laura Mosqueda, et al.
Stroke|March 6, 2010
The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trialSteven C Cramer, Camille Fitzpatrick, Michael Warren, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advance for Nurse Practitioners|December 17, 2009
When should older adults stop driving?Camille Fitzpatrick
Academic Medicine : Journal of the Association of American Medical Colleges|July 9, 2004
University of California, Irvine, College of MedicineAnne E Musser, Camille Fitzpatrick, Laura Mosqueda
Gerontology & Geriatrics Education|October 7, 2006
Student Senior Partnership Program: University of California Irvine School of MedicineCamille Fitzpatrick, Anne Musser, Laura Mosqueda, et al.
Stroke|March 6, 2010
The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trialSteven C Cramer, Camille Fitzpatrick, Michael Warren, et al.
Pageof 1